A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system

Background: Apalutamide is a new drug class, which is approved to treat prostate cancer (PCa). The aim of our study was to assess the safety profiles of apalutamide in real-world through data mining of the United States Food and Drug Administration Adverse Event Reporting System (FAERS). Method: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Zhihong, Xu, Zhiqiang, Zhu, Wei, Yu, Mingming, Ji, Chunmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277739/
https://www.ncbi.nlm.nih.gov/pubmed/37342589
http://dx.doi.org/10.3389/fphar.2023.1101861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277739/
https://www.ncbi.nlm.nih.gov/pubmed/37342589
http://dx.doi.org/10.3389/fphar.2023.1101861

Ejemplares similares